DUKE CANCER REVIEW 2024
Duke Cancer Network's Duke Cancer Review 2024. This year's event will highlight key areas of multidisciplinary care for cancer management, providing a review of the most clinically relevant data presented at ASCO and other recent, standard-setting, professional scientific meetings. Emphasis will be placed on the integration of multi-modal approaches to cancer treatment, cancer care from a community perspective, and strategies for optimizing transitions in goals of care.
Target Audience
Fellows
Medical Students
Nurses
Nurse Practitioners
Physicians
Physician Assistants
Pharmacy Technicians
Pharmacists
Residents
Learning Objectives
Explore multidisciplinary advances in oncology care for genitourinary, gastrointestinal-liver, breast, thyroid, hematologic, and thoracic cancers to improve patient outcomes.
Review multidisciplinary evidence-based oncologic treatment advances through case-based scenario discussions
Examine multidisciplinary approaches and best practices in the management of various cancers.
Christine Eyler MD
Arati Patel
Laura Alder, MD
Hai Salfi ty
Trey Mullikin
Andrea Sitlinger
Chenyu Lin
Christopher Kelsy
Olga James
Akiko Chiba
Diandra Ayala-Peacock
Kara Threatt
Eizabeth Fricklas APP
Lisa Pickett
Rani Bansal
Matt Boyer
Rajan Gupta
Michael Abern
Michael Harrison
Randall Scheri
Jameel Mazaffar
Nivetha Vishnuvardhan
Aman Opneja
Allison Martin
Charles Kim
Eric Schaff
Christopher Jones
Dan Blazer
ABIM MOC
ACPE - Pharmacy Technician
ACPE - Pharmacist
AMA PRA Category 1 Credit(s)
ANCC
Attendance
IACET CEU
JA Credit - AH
Available Credit
- 11.50 ABIM MOC
- 11.50 ACPE - Pharmacist
- 11.50 ACPE - Pharmacy Technician
- 11.50 AMA PRA Category 1 Credit(s)™
- 11.50 ANCC
- 11.50 Attendance
- 1.15 IACET CEU
- 11.50 JA Credit - AH
- 11.50 Approved for AMA PRA Category 1 Credit(s)™